Issue 4/2020
Content (25 Articles)
Homologous recombination deficiency: New biomarkers in innovative treatments
Christian F. Singer
Treating head and neck cancer—A multidisciplinary effort
Gabriele Gamerith, Thorsten Fuereder
Homologous recombination deficiency in epithelial ovarian cancer
Thomas Bartl, Valentina Paspalj, Christoph Grimm
Homologous repair deficiencies and current insights in clinical evaluation of PARP inhibitors in prostate cancer
Maximilian Marhold, Thaïs Topakian
Homologous recombination deficiency in breast cancer
Thomas Bartl, Alex Farr
Transoral robotic surgery in head and neck cancer
Andreas Strobl, Maximilian Hartl, Martin Burian
Particle therapy in head and neck cancer—expanding therapeutic options
Petra Georg
Established treatment concepts for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSSC)
Marcel Kloppenburg, Finn Mildner, Maria Theresia Kasseroler, Daniel Dejaco, Arno Amann
Systemic therapy for metastatic salivary gland tumors—challenges and novel concepts
Christoph Minichsdorfer
Nutritional management during treatment for head and neck cancer
Christina Wagner
Fertility preservation procedures in girls, adolescents and women
Bettina Böttcher, Maren Goeckenjan
Ovarian transposition
Elisabeth Reiser, Bettina Böttcher, Danijela Minasch, Julian Mangesius, Bettina Toth
Future perspectives of fertility preservation in women
Bettina Böttcher, Katharina Winkler-Crepaz
Fertility preservation in women with endometrial cancer
Helena Bralo, Maria Roethlisberger, Kazem Nouri
Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer
Philipp Horvath, Ingmar Königsrainer
Do we still need CRS and HIPEC in colorectal cancer in times of modern chemotherapy and immunotherapy?
Elisabeth Gasser, Pamela Kogler, Andreas Lorenz, Reinhold Kafka-Ritsch, Dietmar Öfner, Alexander Perathoner
Cytoreductive surgery and HIPEC in colorectal cancer—did we get hold of the wrong end of the stick?
Can Yurttas, Oliver M. Fisher, Delia Cortés-Guiral, Sebastian P. Haen, Ingmar Königsrainer, Alfred Königsrainer, Stefan Beckert, Winston Liauw, Markus W. Löffler
Molecular profiling in gastroesophageal cancer—clinical routine and future perspective
Hannah Christina Puhr, Aysegül Ilhan-Mutlu
Molecular profiling in breast cancer—ready for clinical routine?
Kristina A. Tendl, Zsuzsanna Bago-Horvath
Position statement of the Austrian Society for Hematology and Medical Oncology on the use of molecular diagnostics in solid tumors
Gerald Prager, Armin Gerger, Gerald Höfler, Gerald Webersinke, Holger Rumpold, Thomas Winder, Rupert Bartsch, Matthias Preusser, Wolfgang Eisterer
A case report on the long-term survival of a patient with HER2-positive metastatic gastric adenocarcinoma and a short review of the current literature
Hannah Christina Puhr, Aysegül Ilhan-Mutlu